menu
    • menu

    Company profile for Tarsier Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tarsier™ Pharma (doing business as Tarsius Pharma Ltd.) is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and inflammatory ocular diseases. The TRS Platform Technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops ...
    Tarsier™ Pharma (doing business as Tarsius Pharma Ltd.) is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and inflammatory ocular diseases. The TRS Platform Technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops and intravitreal injections. Ocular inflammations are a group of diseases affecting the front and back of the eye. Non-infectious anterior and posterior uveitis are the most known ocular inflammatory diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tarsier PharmaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Zichron Yaacov Zichron Yaacov, Israel 30900, IL
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tarsierpharma.com/
    Linkedin
    Linkedin
    https://il.linkedin.com/company/tarsier-pharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/TarsierPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tarsier: Uveitis-Related Vision Loss Rising, Treatments Needed
    Tarsier: Uveitis-Related Vision Loss Rising, Treatments Needed

    24 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tarsier-pharma-new-data-reveal-sharp-rise-in-vision-loss-from-uveitis-underscoring-urgent-need-for-safer-treatments-302513077.html

    PR NEWSWIRE
    24 Jul 2025
    Share Share
    Tarsier Pharma Appoints Ashley Kline As Chief Commercial Officer
    Tarsier Pharma Appoints Ashley Kline As Chief Commercial Officer

    07 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tarsier-pharma-appoints-ashley-kline-as-chief-commercial-officer-expanding-its-us-presence-302344307.html

    PR NEWSWIRE
    07 Jan 2025
    Share Share
    Tarsier Pharma: Emilee Fulcher Named VP Of Clinical Affairs
    Tarsier Pharma: Emilee Fulcher Named VP Of Clinical Affairs

    28 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tarsier-pharma-announces-the-appointment-of-emilee-fulcher-as-vice-president-of-clinical-affairs-302156720.html

    PR NEWSWIRE
    28 May 2024
    Share Share
    Tarsier Receives FDA Agreement Under SPA for Tarsier-04 Phase 3 Trial of TRS01
    Tarsier Receives FDA Agreement Under SPA for Tarsier-04 Phase 3 Trial of TRS01

    16 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tarsier-pharma-receives-fda-agreement-under-special-protocol-assessment-spa-for-tarsier-04-phase-3-trial-of-trs01-ophthalmic-solution-for-the-treatment-of-non-infectious-uveitis-including-uveitic-glaucoma-302035761.html

    PR NEWSWIRE
    16 Jan 2024
    Share Share
    Tarsier Pharma Announces Successful Type C Meeting with FDA for TRS01
    Tarsier Pharma Announces Successful Type C Meeting with FDA for TRS01

    13 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tarsier-pharma-announces-successful-type-c-meeting-with-fda-for-trs01-in-noninfectious-uveitis-301985947.html

    PR NEWSWIRE
    13 Nov 2023
    Share Share
    Tarsier Announces Results from Phase 3 in Subjects with TRS4VISION trial
    Tarsier Announces Results from Phase 3 in Subjects with TRS4VISION trial

    23 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tarsier-pharma-announces-results-from-a-phase-3-clinical-trial-in-subjects-with-noninfectious-anterior-uveitis-including-subjects-with-uveitic-glaucoma-301907809.html

    PR NEWSWIRE
    23 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search